Search research articles
Contact Us
Filters
Showing results (41-50 of 71) with videos related to
Page
of 8
Sort By:
Molecular and Cellular Neurosciences
|
January 1, 1996
Similarities and differences in the way transmembrane-type ligands interact with the Elk subclass of Eph receptors
R Brambilla, K Brückner, D Orioli, et al.
La Radiologia Medica
|
December 1, 1989
[Quantitative analysis of the lung CT in normal subjects and in patients with noncardiac pulmonary edema]
A Torresin, L Gattinoni, A Pesenti, et al.
Annali Di Igiene : Medicina Preventiva E Di Comunita
|
January 12, 2010
[Analysis of the active components of a complex intervention for the care management of stroke patients: impact on in-hospital mortality]
M Panella, F Leigheb, R Brambilla, et al.
Oncogene
|
March 4, 1998
Ephrin-B3, a ligand for the receptor EphB3, expressed at the midline of the developing neural tube
A D Bergemann, L Zhang, M K Chiang, et al.
Biochimica Et Biophysica Acta
|
May 17, 1991
Bombesin stimulates a high affinity GTPase activity in membranes of Swiss 3T3 fibroblasts
L Morello, E Sturani, M G Cattaneo, et al.
British Journal of Pharmacology
|
August 1, 1997
Characterization of the signalling pathways involved in ATP and basic fibroblast growth factor-induced astrogliosis
C Bolego, S Ceruti, R Brambilla, et al.
The British Journal of Clinical Practice
|
December 1, 1996
The duration of action of inhaled formoterol dry powder
E Quebe-Fehling, R Brambilla, C L Bromly, et al.
The EMBO Journal
|
June 1, 1992
Cloning by functional complementation of a mouse cDNA encoding a homologue of CDC25, a Saccharomyces cerevisiae RAS activator
E Martegani, M Vanoni, R Zippel, et al.
Developmental Neuroscience
|
May 9, 2006
Cerebellar neurons and glial cells are transducible by lentiviral vectors without decrease of cerebellar functions
C Croci, S Fasano, D Superchi, et al.
The Journal of Allergy and Clinical Immunology
|
March 9, 1999
Sustained bronchoprotection, bronchodilatation, and symptom control during regular formoterol use in asthma of moderate or greater severity. The Canadian FO/OD1 Study Group
J M FitzGerald, K R Chapman, G Della Cioppa, et al.
Page
of 8
Search research articles
Search
Showing results (41-50 of 71) with videos related to
Sort By:
Page
of 8
Molecular and Cellular Neurosciences
|
January 1, 1996
Similarities and differences in the way transmembrane-type ligands interact with the Elk subclass of Eph receptors
R Brambilla, K Brückner, D Orioli, et al.
La Radiologia Medica
|
December 1, 1989
[Quantitative analysis of the lung CT in normal subjects and in patients with noncardiac pulmonary edema]
A Torresin, L Gattinoni, A Pesenti, et al.
Annali Di Igiene : Medicina Preventiva E Di Comunita
|
January 12, 2010
[Analysis of the active components of a complex intervention for the care management of stroke patients: impact on in-hospital mortality]
M Panella, F Leigheb, R Brambilla, et al.
Oncogene
|
March 4, 1998
Ephrin-B3, a ligand for the receptor EphB3, expressed at the midline of the developing neural tube
A D Bergemann, L Zhang, M K Chiang, et al.
Biochimica Et Biophysica Acta
|
May 17, 1991
Bombesin stimulates a high affinity GTPase activity in membranes of Swiss 3T3 fibroblasts
L Morello, E Sturani, M G Cattaneo, et al.
British Journal of Pharmacology
|
August 1, 1997
Characterization of the signalling pathways involved in ATP and basic fibroblast growth factor-induced astrogliosis
C Bolego, S Ceruti, R Brambilla, et al.
The British Journal of Clinical Practice
|
December 1, 1996
The duration of action of inhaled formoterol dry powder
E Quebe-Fehling, R Brambilla, C L Bromly, et al.
The EMBO Journal
|
June 1, 1992
Cloning by functional complementation of a mouse cDNA encoding a homologue of CDC25, a Saccharomyces cerevisiae RAS activator
E Martegani, M Vanoni, R Zippel, et al.
Developmental Neuroscience
|
May 9, 2006
Cerebellar neurons and glial cells are transducible by lentiviral vectors without decrease of cerebellar functions
C Croci, S Fasano, D Superchi, et al.
The Journal of Allergy and Clinical Immunology
|
March 9, 1999
Sustained bronchoprotection, bronchodilatation, and symptom control during regular formoterol use in asthma of moderate or greater severity. The Canadian FO/OD1 Study Group
J M FitzGerald, K R Chapman, G Della Cioppa, et al.
Page
of 8